mometasoni furoas 0.25 mg ut mometasoni furoas monohydricus, olopatadinum 6 mg ut olopatadini hydrochloridum, cellulosum microcristallinum et carmellosum natricum, dinatrii phosphas heptahydricus, carmellosum natricum, natrii chloridum, benzalkonii chloridum 0.2 mg, glycerolum, dinatrii edetas, polysorbatum 80, acidum hydrochloridum concentratum, natrii hydroxidum, aqua ad iniectabile q.s. ad suspensionem pro 1 g corresp. mometasoni furoas 25 µg et olopatadinum 600 µg pro dosi.
Packungsbestandteile
Nasal spray
Active Agent
Dose
Mometasoni Furoas
0.25 mg/g
Olopatadine
6 mg/g
Inactive agents
Dose
Acidum Hydrochloridum Concentratum
Benzalkonium Chloride
0.2 mg/g
Carmellose Sodium
Cellulosum Microcristallinum
Dinatrii Edetas
Disodium Phosphate Heptahydrate
Glycerol
Sodium Chloride
Sodium Hydroxide
Polysorbatum 80
Source
Data was imported : 07.01.2026
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
